---

Background: Vasomotor disorders are one of the most painful menopausal complications that negatively affect the quality of life in menopausal women. This study investigated the effects of omega3 fatty acid on vasomotor disorders in menopausal women. Materials and Methods: This randomized, double-blind, placebo-controlled clinical trial study was done on 83 menopausal women aged 45-60 years that had met the inclusion criteria. The participants were randomly assigned to omega3 or placebo groups. Fish oil capsules (containing 300 mg of omega3) or placebo capsules were prescribed to the participants one capsule a day for 8 weeks. Of the 83 patients enrolled, 68 completed the study (omega3 supplement, n=34 placebo n=34). Data collection was done through demographic questionnaire, daily self report, and food frequency questionnaire (FFQ). Data were analyzed by t-test, Chi square, Fiedman, and Mann-Whitney tests using SPSS software version 18. Results: After 8 weeks of intervention, there was a significant difference in HF frequency (p=0.003) and nightsweats frequency (p=0.001) between the two groups. There was no significant difference in HF intensity between the two groups (p=0.2) but reduction of nightsweats intensity was significant between the two groups (p=0.003). Conclusion: Omega3 affected the reduction of HF frequency and nightsweats frequency and intensity but it did not have a significant effect on the severity of HF.

---

Background: Measurement of mean arterial blood pressure is better predictive factor for pregnancy-induced hypertension than measurement of the systolic and diastolic blood pressure or systolic blood pressure. According to the theory of “protective effect of fish oil supplementation on pregnancy-induced hypertension “and the importance of blood pressure control in pregnancy, the present study was conducted to investigate the effect of fish oil supplementation in pregnancy on mean arterial blood pressure. Materials and Methods: In this clinical trial study, 120 healthy pregnant women were randomly divided into two groups of 60 persons. Same prenatal care was performed for both groups and the intervention group was received Salmon fish oil capsule 1000 mg/day, from 16th week to the end of the pregnancy. Systolic and diastolic blood pressure were measured in both groups once every four weeks up to 28th week, every 2 weeks from 28th till 36th week and once every week up to the end of pregnancy. Mean arterial blood pressure was calculated and all gathering data was analyzed with T test and Mann-Whitney test. Results: Mean arterial blood pressure in the intervention and control group was 80.76±5.50 and 78.46±4.50 mmHg which was not significantly different (p>0.05). Conclusion: The results showed that adding fish oil supplements to the diet of pregnant mothers had no significant effect on mean arterial blood pressure.

---

Background: Depression is one of the most commonly observed problems in menopausal women. This study was conducted to determine the effect of omega-3 fatty acids on menopausal depression in women referring to No. 1 Health Clinic of Ahvaz, Iran, in 2010.

Materials and Methods: This randomized double-blind clinical trial was done on 70 menopausal women experiencing various levels of depression. After administering the Hamilton Depression Rating Scale (HAM-D-21), the participants who met the inclusion criteria were randomly divided into intervention group (n=35) receiving a 2gr omega-3 capsules and control group (n=35) receiving 2 gr placebo capsules. After 8 weeks of intervention, data were collected and analyzed by Chi-square, independent t-test, and one-way ANOVA with repeated measures using SPSS software version 17.

Results: Mean depression scores decreased significantly (p<0.001) in the intervention group (13.36±2.23 to 8.72±3.71). Also, mean depression scores decreased (p>0.05) in the control group (13.25±2.04 to 11.78±2.93) however, it was not significant. The comparison of depression scores did not indicate a significant difference regarding the reduction of depression after intervention between the two groups (p=0.08).

Conclusion: According to the findings of this study, administration of omega-3 capsules (2gr/daily) for 8 weeks decreased menopausal depression. However, there was not a significant difference between omga-3 and placebo groups in this study. For a more precise observation of the effects, further studies with longer periods of intervention are needed.

---

Background: Paraoxonase1 activity shows decline in patients with coronary artery disease. The C to T change in the -107 position of promoter is the most important genetic determinant of serum levels of paraoxonase 1. Study of this polymorphism and its relationship with the type of fatty acid composition of phospholipids in HDL particles can be found in the common pursuit of better medicines and considered in drug treatment.

Materials and Methods: In this descriptive study 265 Patients were selected and divided in two groups based on LDL level (131 in case and 134 in control). Information of subjects were collected from questionnaire and the results of biochemistry and molecular tests. Fatty acids of HDL phospholipids were measured with Gas chromatography technic .

Results: PON1aryl esterase activity, had no significant changes after treatment with lovastatin but paraoxonase activity had more significant increases in the CC genitype of -C/T107 polymorphism. Percent of oleic acid, linoleic acid and icosapentanioc acid in HDL phospholipids were increased by lovastatin.

Conclusion: Treatment with lovastatin in the CC genotype is probably more protective effect against cardiovascular disease. Following treatment, in patients with higher paraoxanase 1 activity Oleic acid and linoleic acid have also increased in HDL phospholipids.

---

Background: Acne vulgaris, is a chronic inflammatory disease of the pilosebaceous units. Genetic, environmental factors and nutrition influence on this disease. Recent studies indicate an essential role of nutrition in the development of acne, particularly with the effect on oxidative stress and inflammatory processes. Many studies have reported lower incidence of acne in individuals who receive diets containing large amounts of omega-3. The aim of this study was to determine the probable therapeutic effects of omega-3 for the treatment of acne.

Materials and Methods: In this study, 60 patients with moderate to severe facial acne were randomly divided into two treatment groups: 1) 100 mg doxycycline daily and one placebo capsule Omega -3 2) doxycycline 100 mg daily and one capsule 1000 mg Omega -3. Acne severity was determined based on GAGS system at the beginning of treatment and at the end of the sixth and twelfth weeks of treatment, with photographs obtained from each patient.

Results: There was a significant reduction in acne severity score (GAGS) at the end of sixth and twelfth weeks in the Omega-3 group in comparison to control group that received placebo.

Conclusion: Omega-3 fatty acids can improve moderate to severe inflammatory acne, probably due to their anti-inflammatory properties.